Travoprost ophthalmic solution, 0.004%

DRUG5 trials

Sponsors

Alcon Research, Glaukos Corporation

Conditions

Ocular HypertensionOpen Angle GlaucomaOpen-Angle GlaucomaOpen-angle Glaucoma

Phase 2

Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT00670033

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2008-04-30End: 2008-09-30Updated: 2014-07-10

Divided Dose of TRAVATAN®

CompletedNCT01298687

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2011-02-28End: 2011-04-30Updated: 2017-05-05

Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension

Glaukos CorporationOcular Hypertension, Open Angle Glaucoma

Start: 2023-11-15End: 2024-08-31Target: 250Updated: 2023-12-06

Phase 3

A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

CompletedNCT00465803

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2007-03-31Updated: 2014-07-24

Travoprost 3-Month Safety and Efficacy Study

CompletedNCT01453855

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2011-11-30End: 2012-08-31Updated: 2013-10-18